Category: CannabisNewsWire Release

420 with CNW – Canadian Marijuana Oil Exports Jump 500% in 2019

Canada has made great inroads into the nascent global cannabis industry. As public opinion slowly turns in favor of cannabis, a handful of countries, including Canada, have legalized either medical and adult-use cannabis or both. The Great White North is among the biggest exporters of medical marijuana oil in the world, and according to data from Health Canada, Canadian-produced medical marijuana oil reached more international shores than ever last year.

In 2019, cannabis oil exports were approved for export to at least 17 countries for medical and scientific purposes, but the bulk of the exports involved only a few countries. Overall, 1181 gallons of cannabis oil products were exported for medical and scientific use, and 90% went to three countries. Australia imported roughly 977 gallons of Canadian-made marijuana oil while Germany and Denmark imported 173 gallons and 74 gallons respectively. The remaining 120 gallons of cannabis oil was shipped to 10 or more countries.

Last year’s shipments were almost five times more than the 202 gallons exported from Canada in 2018. Marijuana oil exports in 2019 also exceeded the 8,245 pounds of dried cannabis exported from Canada in 2019. According to Sarah Seale, CEO of Toronto-based Seale & Garland Consulting and a partner at Cannabis Global Consultants, medical cannabis oil is more readily used in medical products, and this makes it more sought after overseas. “There’s a wider market, a higher price point, and it’s a little bit easier to import and export it when you’re dealing with oil,” she says.

Although Canada has had great success with the global medical marijuana export market, fellow progressive countries like Jamaica, Australia, Portugal, and Colombia are itching to jump into the market as well. Despite the threat of increased competition, Seale believes Canadian companies will continue enjoying their advantage, but only if they play their cards right. “Anybody looking to export now is going to be looking at paths that are already open. Canada has the opportunity of looking at the paths that aren’t open yet and making provisions to be the first one in the door in those markets as well.”

Co-founder and CEO of Toronto-based regulatory consulting firm CannaDelta Sherry Boodram says that some countries that have recently legalized cannabis are looking to meet demand through imports before their systems for domestic production are up and running. “A lot of countries don’t have provisions in place to produce dried flower and oil products, so they’re going to look at other countries to obtain those product formats.”

This data is likely to be of great interest to sector players like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) who would also relish the opportunity to get a larger piece of the international market for cannabis products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Youngevity International, Inc.’s (NASDAQ: YGYI) CLR Roasters Expands International Footprint Through Deal to Sell Espresso Brands into Panama

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp production, today announced that its wholly-owned subsidiary CLR Roasters has signed a 5 year contract with H&H Coffee Group Export Corp.to sell CLR’s espresso brands, Café La Rica and Café Cachita into Panama. Per the update, the terms are C.O.D. and F.O.B. Miami, with the initial order of approximately 60,000 units of Café Cachita Espresso bricks expected to ship this week, and a second order of the same amount of the brand Café La Rica planned within 14 days thereafter. “Expanding the distribution of our company owned brands remains a high priority and we are pleased to continue to expand our international footprint,” Youngevity CFO and President Dave Briskie stated in the news release.

To view the full press release, visit http://cnw.fm/8hP5b

About Youngevity International

Youngevity International, Inc. ( NASDAQ: YGYI ) is an multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise.  The Company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Applies for NIH Grant to Support COVID-19 Therapy Studies, Receives Expanded Health Canada License

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its submission of a grant application to the U.S. National Institutes of Health (“NIH”) entitled “In vitro and in vivo animal exploratory pharmacokinetic and preliminary efficacy modelling of select orally administered antiviral compounds following DehydraTECH formulation enhancement.” According to the update, the grant application is for funding to support Lexaria’s second round of planned studies related to COVID-19 treatment possibilities. Additionally, the Company also reported that its subsidiary Lexaria CanPharm ULC has received a new license from Health Canada, issued in accordance with the Cannabis Act and Cannabis Regulations. The new license allows for expanded testing capabilities including sensory testing of cannabis oral products for taste, smell, and additional research and evaluation.

To view the full press release, visit http://cnw.fm/KGZ3n

About Lexaria

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1)  access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – CBD Toxicity Study Informing FDA Regulation Will Commence in July

Since the 2018 Farm Bill legalized the cultivation and sale of industrial hemp and its extracts, the CBD industry has been steadily growing. Effective against a wide range of ailments and most importantly, devoid of cannabis’ infamous high, cannabidiol has quickly become the go-to ingredient for people who have lost faith in pharmaceuticals. However, the industry is barely regulated, and the U.S. Food and Drug Administration (“FDA”) has repeatedly called for stakeholders to provide reliable scientific data, especially on the effects of long term use on the liver.

A group of CBD brands is doing just that. They have sponsored a study to determine any potential liver toxicity and the safety of CBD, and the study will be carried out by Colorado-based clinical research company ValidCare. Slated to commence this July, the clinical study, which was designed with heavy input from a branch of the FDA, is being interpreted as a critical step in providing the agency with scientific data that will guide its efforts to regulate CBD.

The study is officially sponsored by CBD American Shaman, Boulder Botanicals, CBDistillery, Charlotte’s Web Holdings, Columbia Care, Hempfusion, and Kannaway. Each brand donated at least $100,000 for the study, and they will each have the opportunity to invite their consumers to become participants in the study. It was scheduled to start last March but the coronavirus pandemic and the civil unrest currently sweeping through the U.S. pushed the schedule several months ahead.

1,000 subjects will be observed and their liver health monitored from July through September. They will be required to take CBD orally for 60 days before the study then they will record their experiences in journals for the course of 30 days. Additionally, they will also provide blood samples that will be screened under four liver function tests.

“As the market share leader, anchored in science, sponsoring ValidCare’s study made strategic sense for us. This research will provide important clinical data to guide our entire industry while also showing the FDA we’ve heard their requests and are answering their questions with precise data,” says Deanie Elsner, Chief Executive Officer for Charlotte’s Web.

Ever since CBD products hit the shelves, the FDA has been apprehensive and has warned consumers that most of these products may not be safe. The research carried out by ValidCare will provide crucial data on CBD’s effect on the liver and it will inform the FDA on how to move forward with regulating CBD.

It is widely believed that the entire cannabis industry, including Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), will be keen to see the results from this first of a kind study into cannabidiol.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Four States Where Marijuana Legalization Has Been Postponed to 2021 and Beyond

Almost six months into the year, the U.S. is still squarely within the coronavirus’ stranglehold, and the past few weeks have seen rising levels of civil unrest in most states. The economy is in free-fall and health experts warn that the coronavirus pandemic is nowhere near over. With everything that’s going on, it’s easy to forget that Election Day is drawing closer, and a dozen states have at least one ballot initiative devoted to legalizing cannabis.

At least three states are guaranteed to have residents voting on cannabis legalization initiatives in November. However, while there are a few states where legalization in November is a near certainty, some states won’t be going green any time soon. Due to a variety of factors, these states will not be voting to legalize marijuana this coming November

Florida legalized medical cannabis in 2016 and although it was expected that adult-use marijuana would follow suit in 2020, residents will not be voting on a recreational cannabis measure. The Make it Legal Florida campaign garnered the support of certain medical cannabis dispensaries, including MedMen Enterprises, and was able to collect more than 700,000 signatures. However, there simply wasn’t enough time to verify the signatures and refine the language of the proposed constitutional amendment before the 2020 ballot. Additionally, Florida Attorney General Ashley Moody as well as members of the legislature had already expressed clear objections to the proposed amendment.

New York had planned to include marijuana legalization in the state fiscal budget but at the end of March, Governor Andrew Cuomo announced that this would not be likely. He stated that the ongoing coronavirus pandemic had complicated budget discussions and that the cannabis legalization issue was too complex to be discussed in the limited time lawmakers had.

Ohio currently has two recreational marijuana measures on the table for addition to the 2020 ballot but it is unlikely either of the measures will wind up on the November ballot. With social distancing measures and stay at home orders in place to curb the spread of the coronavirus, it has been impossible to collect the required 453,000 signatures. Additionally, the language in one of the measures to regulate cannabis like alcohol needs more fine-tuning and with the deadline in less than 3 weeks, it is unlikely the initiatives will make it to ballot.

Missouri’s quest to legalize cannabis, led by the Missourians for a New Approach campaign, was also affected by the COVID-19 pandemic. As the virus spread and self-isolation and social distancing measures were issued, signature collection became virtually impossible. Advocates attempted to persuade officials to allow the required 170,000 signatures online but Missouri regulators rejected the proposal. Like in New York, Florida, and Ohio, marijuana legalization advocates will have to wait until 2021 or beyond for another shot at marijuana reform.

It would be interesting to hear what cannabis industry actors like SinglePoint, Inc. (OTCQB: SING) have to say about the long-term effects of the derailment of the different legalization campaigns across the country.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Issues LOI for Greenhouse Facility with Potential to More Than Double Production Capacity

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that it has issued a Letter of Intent (“LOI”) to obtain a new 300,000-square-foot greenhouse facility for cannabis cultivation. According to the update, negotiations are underway for the new facility that would more than double the Company’s cannabis production capacity. “In this environment, the market is going to take as much as we can produce given our steady evolution in product quality, and we see those conditions extending for quite some time,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “That strongly points to strategic value in expansion. We have seen recent strong improvements in output, pricing and sales volume, and we are aggressively interested in expanding capacity to capitalize on micro and macro factors to drive more value for our shareholders.”

To view the full press release, visit http://cnw.fm/CfD8e

About Cannabis Strategic Ventures

Cannabis Strategic Ventures Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The Company is Los Angeles-based and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Announces Further Acceleration of Path to Commercialization, Expands Portfolio

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF), a Canadian biotechnology company creating high purity, plant-derived compounds for the global pharmaceutical, health and wellness and consumer packaged goods industries, today announced further acceleration of its path to commercialization following continued scale-up development success and the addition of multiple new cannabinoids for production. “Willow’s scientific and operational success to date has solidified the use of yeast fermentation as a production platform,” Willow’s CEO Trevor Peters stated in the news release. “Our scientific discoveries over the past 14 months have contributed to the development of not one, but five different cannabinoids and our pilot project production samples expected to be available in Q3 of 2020 will make Willow the first to biosynthetically produce material amounts of cannabinoids. We expect to offer a portfolio of ultra-pure, pharmaceutical grade quality cannabinoids by the end of 2021. As we transition from a research-focused company to a production company, we are investigating a variety of end markets, including pharmaceutical and consumer products. We see significant potential in consumer packaged goods for the North American recreation market, where interest for high quality ingredients such as ours is strong.”

To view the full press release, visit http://cnw.fm/zdfC9

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1)  access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

HempNewsBreaks – Marijuana Company of America, Inc. (MCOA) Announces Board Appointment of Marco Guerrero

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced the appointment of Marco Guerrero as a new member of the Company’s board of directors. According to the update, Guerrero is a Brazilian national and currently resides in Sao Paulo, Brazil. Proficient in English, fluent in Spanish and Portuguese, he will be the key executive in charge of opening new operations and distribution channels in Brazil for the HempSmart product line and a strong contributor in the development and implementation of the new HempSmart international strategy. “I am very excited to become part of the MCOA family and to be able to exchange knowledge with such qualified and competent colleagues,” Guerrero stated in the news release. “I am a true believer in the CBD industry, which sooner rather than later will be present in all four corners of the globe. I take this new chapter of my professional career with great honor and will do my best to contribute to the growth of the HempSmart business and to represent the Company’s legitimate interests.”

To view the full press release, visit http://cnw.fm/sZu4O

About Marijuana Company of America Inc.

MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART(TM), which targets general health and well-being; (2) an affiliate marketing and retail sales program to promote and sell its legal hemp-based consumer products containing CBD; (3) joint ventures and acquisitions of business entities engaged in the growth and sale of hemp and cannabis products in jurisdictions where cultivation is legal; and (4) the expansion of its business into ancillary areas as market opportunities in this segment mature and develop. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://cnw.fm/MCOA

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

420 with CNW – High Potency Cannabis Boosts Blood THC Level But Not Impairment, Study Finds

As the state-legal cannabis industry continues advancing in both scientific knowledge and market share, one thing that has become clear is that cannabis today is a lot stronger than it used to be. Studies have found that marijuana in circulation today, both legal and illegal, is up to 5 times stronger than it was in the eighties, and this has raised serious questions on the effect of more potent weed on the body. According to a study of regular cannabis users published by the University of Colorado Boulder in JAMA Psychiatry, smoking high potency marijuana concentrates doesn’t necessarily make you higher.

After studying regular cannabis users who smoke high potency marijuana concentrates and those who smoked regular weed, researchers from the university found that while it did boost THC levels in the blood to more than twice as much as smoking conventional marijuana, it did not make the subjects ‘higher.’ “Surprisingly, we found that potency did not track with intoxication levels. While we saw striking differences in blood levels between the two groups, they were similarly impaired,” says lead author Cinnamon Bidwell, an assistant professor in the Institute of Cognitive Science.

As cannabis is still illegal at the federal level, researchers are prohibited from handling or administering marijuana, so the team from the University of Colorado Boulder had to think outside the box. They used two white Dodge Sprinter vans dubbed the ‘cannavans’ to visit study subjects at their place of residence, where after purchasing their own cannabis and using it in their own homes, the subjects walked out for tests. Bidwell and her colleagues assessed 121 regular cannabis users, half of whom typically used concentrates and half who typically used flowers from the plant.

Flower users were instructed to use flower with either 16% or 24% THC and concentrate users were assigned a product with either 16% or 245% THC. At three time points, that it before, directly after and an hour after they used, researchers drew the subjects’ blood, measured their mood and intoxication level, and assessed their cognitive function and balance. THC levels in concentrate users spiked to 1,016 micrograms per milliliter a few minutes after use while in flower users they peaked at 455 micrograms per milliliter.

Despite this difference in THC blood levels, both groups had a relatively similar level of impairment. “People in the high concentration group were much less compromised than we thought they were going to be. If we gave people that high a concentration of alcohol it would have been a different story,” says Kent Hutchison, co-author of the study and a professor of psychology and neuroscience at CU Boulder who also studies alcohol addiction. The team of researchers hopes to learn the possible long term effects of THC-potent concentrates.

“Does long term, concentrate exposure mess with your cannabinoid receptors in a way that could have long term repercussions? Does it make it harder to quit when you want to? We just don’t know yet.”

The findings of this study are likely to have taken everyone, including The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF), by surprise since it has always been assumed that the more intoxicants one takes, the more impaired they are likely to become.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Missouri Medical Marijuana Growers Face Additional Roadblock Before Planting Crops

At the moment, 33 states have legalized medical cannabis and 11 states plus Washington D.C. have taken things further and legalized recreational use. States with relatively successful legal marijuana programs like California and Colorado have surpassed $1 billion in cannabis tax revenue, and numerous advocates in other states are pushing for legalization. However, the industry is still immature, processes aren’t streamlined across the board and everyone from cultivators to retailers is subject to lengthy and time-consuming verification processes.

Marijuana business owners in Missouri, for instance, already face a lengthy verification process, and they say they have been caught off guard by an additional hurdle imposed by the Missouri Department of Health and Senior Services, which is in charge of overseeing the industry. There are 338 licensed medical marijuana providers, and after being verified by the state, they are now required to go through an additional verification process.

“Once those 338 were chosen by merit, the Department of Health did a verification process where they go through the application with a license holder to prove that everything they put on the application was accurate, correct and conforms to the department’s rules,” says Jack Cardetti, spokesman for MoCannTrade. Once this is completed, there is a final step called a ‘commencement inspection’ before cultivators, manufacturers, and dispensaries can start operating. Inspectors will “come on-site, look at your facility, make sure it has all the security you said it was going to have and make sure that all the promises that were made on the application were followed through on,” says Cardetti.

Only two of 60 cultivators have made it through the process so far near St. Louis. According to Nate Ruby, president of OXG, the verification process “kind of came as a surprise to probably all of us that won licenses.” He has already been verified by the state, and he hopes his commencement inspection is done soon so he can start planting inside his 17,000 square foot greenhouse in Independence. “Hopefully we’ll start growing by July, harvest around October, November, and get the product in our dispensaries.”

Kansas City Cannabis Company hasn’t been verified yet, but Chief Information Officer Nolan Lawrence hopes the final step will be completed soon. However, “that involves a whole lot of paperwork and documentation with investors, owners, and affiliates of the business.”

It isn’t yet clear what sector players like Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) think about the additional steps that their counterparts in Missouri have to go through before getting their operations started.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.